From April 1, 2024 to June 30, 2024, the company has repurchased 326,000 shares, representing 0.07% for CNY 2.69 million. With this, the company has completed the repurchase of 4,186,109 shares, representing 0.92% for CNY 35.01 million under the buyback announced on February 21, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.24 CNY | +1.60% | +3.52% | -24.95% |
07-02 | Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024. | CI |
06-26 | Sinotherapeutics Secures Regulatory Nod for Two Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-24.95% | 510M | |
+26.26% | 45.33B | |
+38.49% | 25.36B | |
+26.83% | 16.7B | |
+20.22% | 14.59B | |
+71.02% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 688247 Stock
- News Sinotherapeutics Inc.
- Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.